Jun-Jie Peng

Osteoglycin (OGN) reverses epithelial to mesenchymal transition and invasiveness in colorectal cancer via EGFR/Akt pathway

Xiang Hu, Ya-Qi Li, Qing-Guo Li et al. · Journal of Experimental & Clinical Cancer Research · 2018 · 80 citations · Full text

Medicine, Cell Biology, Oncology +17

Mucinous Adenocarcinomas Histotype Can Also be a High-Risk Factor for Stage II Colorectal Cancer Patients

Xiang Hu, Ya-Qi Li, Qing-Guo Li et al. · Cellular Physiology and Biochemistry · 2018 · 20 citations · Full text

Medicine, Oncology, Pathology +17

Adjuvant chemotherapy for rectal cancer with complete pathological response (pCR) may not be necessary: a pooled analysis of 5491 patients

Xiang Hu, Ya-Qi Li, Xiao-ji Ma et al. · Cancer Cell International · 2019 · 20 citations · Full text

Medicine, Oncology, Surgery +15

Baseline Peripheral Blood Leukocytosis Is Negatively Correlated With T-Cell Infiltration Predicting Worse Outcome in Colorectal Cancers

Xiang Hu, Ya-Qi Li, Qing-Guo Li et al. · Frontiers in Immunology · 2018 · 19 citations · Full text

Medicine, Hematology, Oncology +17

RNA-seq reveals determinants for irinotecan sensitivity/resistance in colorectal cancer cell lines.

Xin-Xiang Li, Hong-Tu Zheng, Jun-Jie Peng et al. · PubMed · 2014 · 18 citations

Medicine, Oncology, Pharmacology +17